ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø

ÀÇ·áÁø »çÁø
ÃÖ¿µ¹Î ±³¼ö
Àü¹®¼¾ÅÍ ³ú½Å°æ¼¾ÅÍ
Áø·á°ú Á¤½Å°Ç°­ÀÇÇаú HOME

Àü¹®Áø·áºÐ¾ß

°Ç¸ÁÁõ, Ä¡¸Å, ¾ËÃ÷ÇÏÀ̸Ӻ´, ºÒ¸éÁõ, ±âºÐÀå¾Ö, ºÒ¾ÈÀå¾Ö, Á¶Çöº´, ¼Ò¾ÆÃ»¼Ò³â Á¤½ÅÀå¾Ö

ÀüÈ­ ¿¹¾à 1522-2500

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2025-05-05 ~ 2025-05-10)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¼¾ÅÍÁø·á¼¾ÅÍÁø·á
¿ÀÈÄ ¼¾ÅÍÁø·á

ÇзÂ

ÇзÂ

2007¼­¿ï´ëÇб³ Àǰú´ëÇÐ Çлç

2013¼­¿ï´ëÇб³ ´ëÇпø ÀÇÇаú ¼®»ç

2015¼­¿ï´ëÇб³ ´ëÇпø ÀÇÇаú ¹Ú»ç

°æ·Â

°æ·Â

2007 ~ 2012¼­¿ï´ëÇб³º´¿ø ¼ö·Ã ¹× Àü°øÀÇ ¼ö·á

2012 ~ 2015¼­¿ï´ëÇб³º´¿ø Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó°­»ç

2015 ~ 2018¿ï»ê´ëÇб³º´¿ø ÀÓ»óÁ¶±³¼ö / Á¶±³¼ö

2018 ~ 2024ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø ÀÓ»óÁ¶±³¼ö / Á¶±³¼ö

2024 ~ 2025¹Ì±¹ ÇϹöµå´ëÇб³ Àǰú´ëÇÐ ¹æ¹®±³¼ö

2024 ~ ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø ºÎ±³¼ö

ÇÐȸȰµ¿

ÇÐȸȰµ¿

Alzheimer¡¯s Association International Society to Advance Alzheimer¡¯s Research and Treatment (ISTAART) Membership

´ëÇѳúÀÚ±ØÇÐȸ ÀÌ»ç

Çѱ¹Á¤½Åº´¸®Áø´ÜºÐ·ùÇÐȸ ÀÌ»ç

´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¤È¸¿ø

´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Á¤È¸¿ø

Çѱ¹Ä¡¸ÅÇùȸ Àü¹®À§¿ø

¼ö»óÀÌ·Â

¼ö»óÀÌ·Â

Outstanding Research Award, 6th Symposium on COgnition, Sleep, MOod and Stress, Seongnam, Korea

BEST POSTER AWARD, 1st BESETO International Psychiatry Conference, Seoul, Korea.

³í¹®/Àú¼­

³í¹®/Àú¼­
±¹Á¦ÇÐȸÁö ¹ßÇ¥³í¹®
1. Prevalence and Clinical Features of Probable REM Sleep Behavior Disorder-An Epidemiological Study in Osan City. Sleep Med Psychophysiol. 2011;18(1): 23-28.

2. Association of homocysteine with hippocampal volume independent of cerebral amyloid and vascular burden. Neurobiol Aging. 2014 Jul;35(7):1519-25.

3. Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease. Int J Geriatr Psychiatry. 2016 Jul;31(7):731-9.

4. Subjective memory complaint as a useful tool for the early detection of Alzheimer's disease. Neuropsychiatr Dis Treat. 2018 Sep 24;14:2451-2460.

5. Combination of the CAGE and serum gamma-glutamyl transferase: an effective screening tool for alcohol use disorder and alcohol dependence. Neuropsychiatr Dis Treat. 2019 May 31;15:1507-1515.

6. Sleep experiences during different lifetime periods and in vivo Alzheimer pathologies. Alzheimers Res Ther. 2019 Sep 12;11(1):79.

7. MMSE Subscale Scores as Useful Predictors of AD Conversion in Mild Cognitive Impairment. Neuropsychiatr Dis Treat. 2020;16:1767-1775.

8. Olanzapine-induced Concurrent Tardive Dystonia and Tardive Dyskinesia in Schizophrenia with Intellectual Disability: A Case Report. Clin Psychopharmacol Neurosci. 2020 Nov 30;18(4):627-630.

9. Association between enlarged perivascular spaces and cognition in a memory clinic population. Neurology. 2022 Sep 27;99(13):e1414-e1421.

10. Association Between Copper and Global Cognition and the Moderating Effect of Iron. Front Aging Neurosci. 2022 Mar 29;14:811117.

11. Brain Amyloid Index as a Probable Marker Bridging Between Subjective Memory Complaint and Objective Cognitive Performance. Front Neurosci. 2022 Jul 4;16:912891.

12. Association of a history of sleep disorder with risk of mild cognitive impairment and Alzheimer's disease dementia. Psychiatry Investig. 2022 Oct;19(10):840-846.

13. High-intensity walking in midlife is associated with improved memory in physically capable older adults. Alzheimers Res Ther. 2023 Aug 29;15(1):143.

¾ð·Ðº¸µµ